Point of Care Diagnostics Market Size and Scope 2031
Point of Care Diagnostics Market: Size and Share
-
CAGR (2024 - 2031)13.0% -
Market Size 2024
US$ 37.93 Billion -
Market Size 2031
US$ 88.83 Billion

Market Dynamics
- Increasing Prevalence of Infectious Diseases
- Integration Of Artificial Intelligence (AI) and Machine Learning (ML)
- Rising Product Launches and Advancements by Market Players in Emerging Economies
Market Segmentation

- Glucose Monitoring
- Infectious Disease Testing
- Cardiometabolic Testing
- Pregnancy and Fertility Testing
- Coagulation Testing
- Tumor/Cancer Marker Testing
- Cholesterol Testing
- Urinalysis Testing
- Hematology Testing
- Thyroid Testing

- OTC
- Prescription

- Blood
- Urine

- Healthcare Facilities
- Homecare
Point of Care Diagnostics Market Players Density: Understanding Its Impact on Business Dynamics
The Point of Care Diagnostics Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Point of Care Diagnostics Market are:
- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories Inc
- Abbott Laboratories
- QIAGEN NV
- Siemens AG
Disclaimer: The companies listed above are not ranked in any particular order.

- Get the Point of Care Diagnostics Market top key players overview